주요우울장애에 대한 인지치료의 효과 = The Effects of Cognitive Therapy in Major Depressive Disorder

다국어 초록 (Multilingual Abstract)

Objectives : Cognitive therapy is the most extensively researched psychological treatment for nonpsychotic unipolar outpatient depressive disorders. This review focused on the utility of this approach in severe or chronic depressive disorders, in relapse prevention and also on the potential benefits of combining cognitive therapy with medication. Methods : The author reviewed original studies and quantitative analyses on the effects of cognitive therapy, predictors of response, and neuroimaging studies of cognitive therapy in major depressive disorder. The sources used for the literature search were data bases : PubMed, EMBASE, CDSR on the internet, references in papers or books. Results : This review suggests that cognitive therapy is as effective as antidepressant medication in severe depressive disorders. And cognitive therapy can be an effective alternative to antidepressant medication. Patients benefited significantly more from combined cognitive therapy and antidepressant treatment than from either treatment alone. Most importantly, the addition of cognitive therapy to usual treatment appears to protect against future relapse in individuals known to be at high risk of repeated episodes of depression. In addition, subjects who received cognitive therapy showed significantly greater improvements in chronic depression than receiving antidepressant medication. Pooled data suggests that there is a significant relationship between the therapist's level of training or experience, the type of therapy used and patient outcome. Recent functional imaging studies examining brain changes following cognitive therapy report a variety of regional effects, but there is no consistent pattern across the few published studies. Conclusion : Cognitive therapy has proved beneficial in treating depressive patients. Despite empirical data supporting its efficacy, there are still problems in gaining access to cognitive therapy in clinical practice.

참고문헌 (Reference)

• 1 Blatt SJ, "When and how perfectionism impedes the brief treatment of depression:further analysis oh the National Institute of Mental Health Treatment of Depression Collaborative Research Program" 66 : 423-428, 1998
• 2 Thase ME, "Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations" 54 : 1009-1015, 1997
• 3 Burns DD, "Therapeutic empathy and recovery from depression in cognitive-behavioural therapy:a structural equation model" 60 : 441-449, 1992
• 4 Blackburn IM, "The efficacy of cognitive therapy in depression:a treatment trial using cognitive therapy and pharmacotherapy,each alone and in combination" 139 : 181-189, 1981
• 5 Scott J, "The effects of cognitive therapy on psychological symptoms and social functioning in residual depression" 177 : 440-446, 2000
• 6 Keller M, "The acute treatment of chronic depression:a comparison of nefazadone,cognitive behavioural analysis system of psychotherapy,and their combination" 342 : 1462-1470, 2000
• 7 Fava GA, "Six-year outcome of cognitive behavior therapy for prevention of recurrent depression" 161 : 1872-1876, 2004
• 8 Fava GA, "Six year outcome for cognitive behavioural treatment of residual symptoms in major depression" 155 : 1443-1445, 1998
• 9 Thase ME, "Severity of depression and response to cognitive behaviour therapy" 148 : 784-789, 1991
• 10 Ochsner KN, "Rethinking feeling:an FMRI study of the cognitive regulation of emotion" 14 : 1215-1229, 2002
• 11 Kuyken W, "Response to cognitive therapy in depression:the role of maladaptive beliefs and personality disorders" 69 (69): 560-566, 2001
• 12 Brody AL, "Regional brain metabolic changes in patient with major depression treated with either paroxetine or interpersonal therapy: preliminary findings" 58 : 631-640, 2001a
• 13 Robinson LA, "Psychotherapy for the treatment of depression" 108 : 30-49, 1990
• 14 Freud, "Project for a scientific psychology" standard edition 1 : 295-397, 1895
• 15 Janicak PG, "Principles and Practice of Psychopharmacotherapy" williams & wilkins : 1993-,
• 16 Paykel ES, "Prevention of relapse in residual depression by cognitive therapy. a controlled trial" 56 : 829-835, 1999
• 17 Hollon SD, "Prevention of relapse following cognitive therapy versus medication in moderate to severe depression" 62 (62): 417-422, 2005
• 18 Kraft D, "Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial" 58 : 381-388, 2001
• 19 Sotsky SM, "Patient predictors of response to psychotherapy and pharmacotherapy:findings of the NIMH Treatment of Depression Collaborative Research Program" 148 : 997-1008, 1991
• 20 Rauch SL, "Neuroimaging and neurocircuitry models pertaining to the neurosurgical treatment of psychiatric disorders" 14 : 213-223, 2003
• 21 Dougherty DD, "Neuroimaging and clinical models of depression" 5 : 138-159, 1997
• 22 Horwitz B, "Neural modeling,functional brain imaging,and cognition" 3 : 91-98, 1999
• 23 Elkin I, "National Institute of Mental Health Treatment of Depression Collaborative Research Programme:general effectiveness of treatment" 46 : 971-982, 1989
• 24 Goldapple K, "Modulation of cortical-limbic pathways in major depression" 61 : 34-41, 2004
• 25 Greenberger D, "Mind over mood:a cognitive therapy treatment manual for clients" Guilford Press 1995
• 26 Crits-Christoph P, "Meta-analysis of therapist effects in psychotherapy outcome studies" 1 : 81-91, 1991
• 27 Peselow ED, "Melancholic/endogenous depression and response to somatic treatments and placebo" 149 : 1324-1334, 1992
• 28 DeRubeis RJ, "Medications versus cognitive behaviour therapy for severely depressed ourpatients:mega-analysis of four randomised comparisons" 156 : 1007-1013, 1999
• 29 Whisman AM, "Mediators and moderators of change in cognitive therapy of depression" 114 : 248-265, 1993
• 30 Keller MB, "Long-term outcome of episodes of major depression" 252 : 788-792, 1984
• 31 Kirsh I, "Listening to Prozac but hearing placebo:a meta-analysis of antidepressant medication" 1 : 1-17, 1998
• 32 Mayberg HS, "Limbic-cortical dysregulation:a proposed model of depression" 9 : 471-481, 1997
• 33 Thase ME, "Is psychothrapy and effective treatment for melancholia and other severe depressive states" 54 : 1-19, 1999
• 34 Teasdale JD, "How does cognitive therapy prevent relapse in residual depression - evidence from a controlled trial" 69 (69): 347-357, 2001
• 35 Friston K, "Functional and effective connectivity in neuroimaging:a synthesis" 2 : 58-78, 1994
• 36 Drevets WC, "Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression" 126 : 413-431, 2000
• 37 Shapiro DA, "Effects of treatment duration and severity of depression on the effectivenss of cognitive/behavioural and psychodynamic/interpersonal psychotherapy" 62 : 522-534, 1994
• 38 Evan MD, "Differential relapse following cognitive therapy and pharmacotherapy for depression" 49 : 802-808, 1992
• 39 Kovacs M, "Depressed outpatients treated with cognitive therapy or pharmacotherapy:a one-year follow-up" 38 : 33-39, 1981
• 40 Rush AJ, "Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients" 1 : 17-37, 1977
• 41 Beck AT, "Cognitive therapy:Basics and Beyond" Guildford 1995
• 42 Scott J, "Cognitive therapy of affective disorders:a review" 37 : 1-11, 1996
• 43 Hollon SD, "Cognitive therapy for depression:conceptual issues and clinical efficiency" 62 : 270-275, 1993
• 44 Beck AT, "Cognitive therapy and the emotional disorders" 1976
• 45 Hollon SD, "Cognitive therapy and pharmacotherapy for depression:singly or in combination" 49 : 774-781, 1992
• 46 Murphy GE, "Cognitive therapy and pharmacotherapy" 41 : 33-41, 1984
• 47 Thase ME, "Cognitive behaviour therapy of endogenous depression.Part 1:an outpatient clinical replication series" 22 : 457-467, 1991
• 48 Gortner ET, "Cognitive bahavioural treatment for depression:relapse prevention" 66 : 377-384, 1998
• 49 Paquette V, "Change the mind and you change the brain:effects of cognitive-behavioral therapy on the neural correlates of spider phobia" 18 : 401-409, 2003
• 50 Brody AL, "Brain metabolic changes associated with symptom factor improvement in major depressive disorder" 50 : 171-178, 2001b
• 51 Martin SD, "Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride:preliminary findings" 58 : 641-648, 2001
• 52 Beck AT, "Beyond belief: a theory of modes, personality, and psychopathology" Guildford 1-25, 1996
• 53 Dobson KS, "A meta-analysis of the efficacy of cognitive therapy for depression" 57 : 414-419, 1989
• 54 Gloaguen V, "A meta-analysis of the effects of cognitive therapy in depressed patients" 49 : 59-72, 1998
• 55 Wampold BE, "A meta-(re)analysis of the effects of cognitive therapy versus other therapies for depression" 68 : 159-165, 2002
• 56 Keller MB, "A comparison of nefazodone the cognitive behavioral-analysis system of psychotherapy and their combination for the treatment of chronic depression" 342 : 1462-1470, 2000